Immediate Impact
2 standout
Citing Papers
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options
2022 Standout
Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
2021 Standout
Works of G. Vagstad being referenced
Neoadjuvant endocrine therapy with palbociclib in patients with high-risk breast cancer
2019
Neoadjuvant olaparib monotherapy in primary triple negative breast cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| G. Vagstad | 9 | 14 | 6 | 4 | 25 | ||
| Beverly Lester | 10 | 2 | 10 | 3 | 3 | 21 | |
| Glenys Round | 13 | 1 | 22 | 5 | 4 | 39 | |
| Georgina Sposetti | 5 | 6 | 6 | 6 | 3 | 25 | |
| Duncan Simpson | 12 | 2 | 8 | 10 | 5 | 29 | |
| Arturo Zapata | 6 | 3 | 11 | 13 | 3 | 28 | |
| Neil E. Fleshner | 9 | 1 | 10 | 8 | 5 | 27 | |
| Cathryn Phillips | 8 | 7 | 7 | 9 | 6 | 28 | |
| M Angeles Montero | 3 | 4 | 9 | 12 | 3 | 36 | |
| Atílio Morais | 17 | 3 | 16 | 6 | 4 | 28 | |
| S Hamrang-Yousefi | 7 | 1 | 24 | 8 | 5 | 34 |
All Works
Loading papers...